Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Purine analogues compared with mesalamine or 5-ASA for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.

Shen FC, Zhang HJ, Zhao XD, Cao RS, Shi RH.

Int J Clin Pract. 2012 Aug;66(8):758-766. doi: 10.1111/j.1742-1241.2012.02965.x.

PMID:
22805268
2.

Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.

Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P.

Am J Gastroenterol. 2011 Apr;106(4):617-29. doi: 10.1038/ajg.2011.71. Epub 2011 Mar 15. Review.

PMID:
21407190
3.

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.

Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH.

Gastroenterology. 2004 Sep;127(3):723-9.

PMID:
15362027
4.

[Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].

Domènech E, Scala L, Bernal I, García-Planella E, Casalots A, Piñol M, Esteve-Comas M, Cabré E, Boix J, Gassull MA.

Gastroenterol Hepatol. 2004 Dec;27(10):563-7. Spanish.

PMID:
15574279
5.

5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.

Ford AC, Khan KJ, Talley NJ, Moayyedi P.

Am J Gastroenterol. 2011 Mar;106(3):413-20. doi: 10.1038/ajg.2010.317. Epub 2010 Aug 17. Review.

PMID:
20717106
6.

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR; International AZT-2 Study Group.

Gut. 2010 Jun;59(6):752-9. doi: 10.1136/gut.2009.194159.

PMID:
20551460
7.

Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, Imbesi V, Molteni M, Danelli PG, Taschieri AM, Bianchi Porro G.

Gastroenterology. 2004 Sep;127(3):730-40.

PMID:
15362028
8.

A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis.

Nikfar S, Rahimi R, Rezaie A, Abdollahi M.

Dig Dis Sci. 2009 Jun;54(6):1157-70. doi: 10.1007/s10620-008-0481-x. Epub 2008 Sep 4. Review.

PMID:
18770034
9.

[Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].

Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J.

Gastroenterol Hepatol. 2000 Oct;23(8):374-8. Spanish.

PMID:
11227650
10.

Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.

Ford AC, Khan KJ, Sandborn WJ, Kane SV, Moayyedi P.

Am J Gastroenterol. 2011 Dec;106(12):2070-7; quiz 2078. doi: 10.1038/ajg.2011.296. Epub 2011 Sep 6. Review.

PMID:
21894226
11.

Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis.

Rahimi R, Nikfar S, Rezaie A, Abdollahi M.

Dig Dis Sci. 2009 Apr;54(4):712-21. doi: 10.1007/s10620-008-0428-2. Epub 2008 Aug 6. Review.

PMID:
18683049
12.

A network meta-analysis on the efficacy of 5-aminosalicylates, immunomodulators and biologics for the prevention of postoperative recurrence in Crohn's disease.

Yang Z, Ye X, Wu Q, Wu K, Fan D.

Int J Surg. 2014;12(5):516-22. doi: 10.1016/j.ijsu.2014.02.010. Epub 2014 Feb 25.

13.

Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.

Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, Papi C, Viscido A, Cammà C, Corrao G, Latella G.

Aliment Pharmacol Ther. 2003 Feb 15;17(4):517-23.

14.

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R; Cochrane Haematologic Malignancies Group.

Cancer Treat Rev. 2006 Aug;32(5):377-89. Epub 2006 Jun 21. Review.

PMID:
16793209
15.

Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine.

Ren J, Wu X, Liao N, Wang G, Fan C, Liu S, Ren H, Zhao Y, Li J.

J Int Med Res. 2013 Feb;41(1):176-87. doi: 10.1177/0300060512474744. Epub 2013 Jan 24.

PMID:
23569144
16.

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.

Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF.

Am J Gastroenterol. 2009 Aug;104(8):2089-96. doi: 10.1038/ajg.2009.301. Epub 2009 Jun 30. Review.

PMID:
19568226
17.

Biologics for the prevention of postoperative Crohn's disease recurrence: A systematic review and meta-analysis.

Zhao Y, Ma T, Chen YF, He XY, Ren LH, Chen J, Fang L, Su JW, Zhang HJ, Shi RH.

Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):637-49. doi: 10.1016/j.clinre.2015.03.007. Epub 2015 May 7. Review.

PMID:
25958300
18.

Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)

Caprilli R, Corrao G, Taddei G, Tonelli F, Torchio P, Viscido A.

Dis Colon Rectum. 1996 Mar;39(3):335-41.

PMID:
8603558
19.

Meta-analysis of medical treatment and placebo treatment for preventing postoperative recurrence in Crohn's disease (CD).

Cao Y, Gao F, Liao C, Tan A, Mo Z.

Int J Colorectal Dis. 2009 May;24(5):509-20. doi: 10.1007/s00384-009-0640-3. Epub 2009 Jan 27.

PMID:
19172283

Supplemental Content

Support Center